Bugworks Research Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 23
Employees
  • Latest Deal Type
  • Series B1
  • Latest Deal Amount
  • $7.5M
Latest Deal Amount
  • Investors
  • 18

Bugworks Research General Information

Description

Developer of drugs for the treatment of antibiotic resistant bacterial infections. The company discovers antibiotics for the treatment of antibiotic resistant bacterial infections using systems biology, structural biology and medicinal chemistry in order to reduce efflux mediated drug resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 110 A, EVOMA, 88, Borewell Road
  • Whitefield
  • Bangalore, Karnataka 560066
  • India
+91 080 0000 0000

Bugworks Research Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bugworks Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series B1) 23-Apr-2020 $7.5M 0000 Completed Pre-Clinical Trials
6. Grant 08-Dec-2019 000 000.00 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 13-Aug-2018 000 000.00 0000 Completed Product In Beta Test
4. Grant 24-Jul-2017 00.00 00.00 Completed Generating Revenue
3. Seed Round 20-Nov-2015 00.00 00.00 00.00 Completed Generating Revenue
2. Accelerator/Incubator 19-Jul-2014 Completed Generating Revenue
1. Grant 04-Feb-2014 $500K Completed Startup
To view Bugworks Research’s complete valuation and funding history, request access »

Bugworks Research Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 3,537,819 $0.000100 $1.7 $1.7 1x $1.7 14.73%
Seed 4,126,230 $0.000100 $0.63 $0.63 1x $0.63 17.63%
To view Bugworks Research’s complete cap table history, request access »

Bugworks Research Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs for the treatment of antibiotic resistant bacterial infections. The company discovers antibiotics for
Drug Discovery
Bangalore, India
23 As of 2020
0000
00000000000 0000

0000000

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000 000000000
Brighton, United Kingdom
0 As of 0000
000.00
00.00 0000-00-00
00000000 000.00

00000000

si ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit ess
0000 000000000
Basel, Switzerland
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bugworks Research Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Destiny Pharma Formerly VC-backed Brighton, United Kingdom 0 000.00 00000000 000.00
000000000 Venture Capital-Backed Basel, Switzerland 00 000.00 00000000000 000.00
00 00000000 Private Debt Financed Paris, France 00 000.00 000000000 000.00
00000000 Angel-Backed Boston, MA 0 00.000 0000000000 00.000
0000000 0000000000 Venture Capital-Backed Cambridge, United Kingdom 0 00.00 0000000000 0 00.00
You’re viewing 5 of 12 competitors. Get the full list »

Bugworks Research Executive Team (7)

Name Title Board Seat Contact Info
Anand Anandkumar Ph.D Co-Founder, Chief Executive Officer & Board Member
V Balasubramanian Co-Founder, President, Chief Operating Officer & Board Member
Santanu Datta Ph.D Co-Founder, Chief Scientific Officer & Board Member
Shahul Hameed Vice President, Discovery
You’re viewing 4 of 7 executive team members. Get the full list »

Bugworks Research Board Members (4)

Name Representing Role Since
Anand Anandkumar Ph.D Bugworks Research Co-Founder, Chief Executive Officer & Board Member 000 0000
Atsushi Usami Ph.D The University of Tokyo Edge Capital Board Member 000 0000
Santanu Datta Ph.D Bugworks Research Co-Founder, Chief Scientific Officer & Board Member 000 0000
V Balasubramanian Bugworks Research Co-Founder, President, Chief Operating Officer & Board Member 000 0000
To view Bugworks Research’s complete board members history, request access »

Bugworks Research Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bugworks Research Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Carica Investments Other 000 0000 000000 0
Global Brain Venture Capital Minority 000 0000 000000 0
3one4 Capital Venture Capital Minority 000 0000 000000 0
Acquipharma Venture Capital Minority 000 0000 000000 0
I.M Holdings B.V Corporation Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »